BIOBOT Surgical raises $15.4 million to expand its operations in the US and accelerate its robotic prostate cancer diagnosis platform, led by ClavystBio.
Amount Raised
$15.4 Million
Round Type
Funding Round
SingaporeManufacturingBiotechnologyHealth CareMedicalMedical DeviceInvestors
Description
BIOBOT Surgical has raised US$15.4 million in funding to expand its presence in the United States. The investment will support the company's growth, product development, and the adoption of its robotic platform. ClavystBio led the funding round, with participation from ZIG Ventures. This investment highlights the confidence in Singapore's medtech sector and the demand for robotic-assisted technologies.
Quick answer
Biobot Surgical raised $15.4 Million in a Funding Round round, dated June 29, 2026. Investors: ClavystBio and Zig Ventures. Biobot Surgical is based in Singapore, Southeast Asia, Singapore.
- How much did Biobot Surgical raise?
- Biobot Surgical raised $15.4 Million in a Funding Round round on June 29, 2026.
- Who invested in Biobot Surgical?
- ClavystBio and Zig Ventures are named as investors in this round.
- What does Biobot Surgical do?
- BIOBOT is a medical technology company dedicated to redefining the standard of care in urology through technological innovation.
- Where is Biobot Surgical based and how big is it?
- Biobot Surgical is based in Singapore, Southeast Asia, Singapore.
- Who are the decision-makers at Biobot Surgical?
- Fundz holds 2 contacts at Biobot Surgical, including the President. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as Biobot Surgical that raised within 45 days of this round, from Fundz verified event records.
- Conavi Medical raised $3.5M (Seed) on August 12, 2026.
- QTREX Quantum Ltd raised $10M on July 22, 2026.
- Endo Tools Therapeutics raised $23M (Series C) on July 16, 2026.
- IceCure Medical raised $17M on June 17, 2026.
- Icarus Medical raised $7.2M (Series A) on June 17, 2026.
- FesariusTherapeutics raised $20M (Series A) on June 10, 2026.
Who to call at Biobot Surgical, and when
A new round usually means Biobot Surgical is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Biobot Surgical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Biobot Surgical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Biobot Surgical. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Biobot Surgical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Biobot Surgical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.